Outlook Therapeutics (OTLK) Insider Trading & Ownership $1.44 +0.05 (+3.60%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Outlook Therapeutics (NASDAQ:OTLK) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.40%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$50,695.24Number OfInsiders Selling(Last 12 Months)0 Get OTLK Insider Trade Alerts Want to know when executives and insiders are buying or selling Outlook Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address OTLK Insider Buying and Selling by Quarter Ad Brownstone ResearchMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.Click here to watch this demo and decide for yourself. Outlook Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/26/2024Lawrence A KenyonCFOBuy5,000$5.69$28,450.00 3/28/2024Yezan Munther HaddadinDirectorBuy1,882$11.82$22,245.24 (Data available from 1/1/2013 forward) OTLK Insider Trading Activity - Frequently Asked Questions Who is on Outlook Therapeutics's Insider Roster? The list of insiders at Outlook Therapeutics includes C Russell Trenary III, Jeff Evanson, Kurt J Hilzinger, Lawrence A Kenyon, Terry Dagnon, and Yezan Munther Haddadin. Learn more on insiders at OTLK. What percentage of Outlook Therapeutics stock is owned by insiders? 3.40% of Outlook Therapeutics stock is owned by insiders. Learn more on OTLK's insider holdings. Which Outlook Therapeutics insiders have been buying company stock? The following insiders have purchased OTLK shares in the last 24 months: Lawrence A Kenyon ($28,450.00), and Yezan Munther Haddadin ($22,245.24). How much insider buying is happening at Outlook Therapeutics? Insiders have purchased a total of 6,882 OTLK shares in the last 24 months for a total of $50,695.24 bought. Which Outlook Therapeutics insiders have been selling company stock? The following insiders have sold OTLK shares in the last 24 months: Jeff Evanson ($161,532.40), and Terry Dagnon ($592,800.00). How much insider selling is happening at Outlook Therapeutics? Insiders have sold a total of 32,520 Outlook Therapeutics shares in the last 24 months for a total of $754,332.40 sold. Outlook Therapeutics Key ExecutivesMr. Ralph H. Thurman (Age 75)Independent Executive Chairman Compensation: $207.5kMr. C. Russell Trenary III (Age 66)President, CEO & Director Compensation: $610.9kMr. Lawrence A. Kenyon CPA (Age 58)Executive VP, CFO, Treasurer, Company Secretary & Director 1 recent tradesMr. Jeffrey Evanson (Age 55)Chief Commercial Officer Compensation: $451.17kMs. Alicia TozierSenior Vice President, Marketing & Market AccessMr. Joel PrieveSenior Vice President of Licensing and M&ADr. Surendra Sharma M.D.Senior Vice President of Medical AffairsDr. Jennifer M. Kissner Ph.D.Senior Vice President of Clinical Development & Regulatory AffairsMr. Jedd ComiskeySenior VP - Head of Europe More Insider Trading Tools from MarketBeat Related Companies Cabaletta Bio Insider Trading Vaxart Insider Trading Enanta Pharmaceuticals Insider Trading Neoleukin Therapeutics Insider Trading Applied Therapeutics Insider Trading Protalix BioTherapeutics Insider Trading Cassava Sciences Insider Trading Aligos Therapeutics Insider Trading Editas Medicine Insider Trading Acumen Pharmaceuticals Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NASDAQ:OTLK) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Outlook Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Outlook Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
